Selective Targeting of Protein Arginine Methyltransferase 1 (PRMT1) Mutant Activity by a Small Molecule Activation...

Area of Science:

• Biochemistry
• Molecular Biology
• Chemical Biology

Background:

• Protein arginine methyltransferase 1 (PRMT1) is crucial for protein post-translational modification.
• PRMT1 overexpression is linked to cancer development and poor patient prognosis.
• Selective inhibition of PRMT isoforms is challenging due to high sequence similarity.

Purpose of the Study:

• To develop a novel method for selective modulation of PRMT1 activity using small molecules.
• To create a chemical genetics strategy for real-time control of PRMT1 function.

Main Methods:

• Site-directed mutagenesis was used to create enzymatically inactive PRMT1 variants (e.g., PRMT1-H293G).
• An exogenous small molecule (4-methylimidazole) was employed to activate the mutated PRMT1.
• Enzymatic activity was measured using single-substrate and proteome-wide assays.

Main Results:

• The small molecule 4-methylimidazole selectively enhanced PRMT1-H293G activity by 8.6-fold.
• This activation was specific to PRMT1, with no significant effect on other PRMT isoforms.
• The selective enhancement was validated in both simple and complex protein mixtures.

Conclusions:

• A unique chemical genetics approach enables selective modulation of PRMT1 activity.
• This strategy allows for precise, real-time dissection of individual PRMT isoform functions.
• The method holds potential for advancing cancer research and understanding cellular signaling pathways.